The Venous Center

Filter Your Results

 

News

 

The Challenges of the Common Femoral Vein in Deep Vein Thrombosis

Stephen A. Black, MD, FRCS(Ed), FEBVS

July 2017—How to assess involvement of the common femoral vein in patients with acute and chronic deep vein thrombosis and the approach to treatment in patients with chronic disease.

Treating the DVO Picture: Significance of Imaging in Relation to the Complaints of the Patient

Vincent G. Helyar, MBBS, MSc, FRCR, EBIR; Stephen A. Black, MD, FRCS(Ed), FEBVS; and Narayan Karunanithy, MBBS, MRCS, FRCR, EBIR

July 2017—A structured approach to the imaging workup for deep venous obstruction of the lower limbs.

Results Published for Bio2 Medical's Angel Catheter Pivotal Study

June 29, 2017 -- Bio2 Medical announced that the results of the pivotal study for the company's Angel catheter were published by Victor F. Tapson, MD, et al online ahead o…

FDA Grants Priority Review of 10-mg Dose of Xarelto to Reduce Risk of Recurrent VTE

June 28, 2017 -- Janssen Research & Development, LLC announced that the US Food and Drug Administration (FDA) accepted for priority review a supplemental new drug applicat…

FDA Approves Bevyxxa for Hospital and Extended-Duration VTE Prevention in Acutely Ill Patients

June 28, 2017 -- Portola Pharmaceuticals Inc. recently announced that the US Food and Drug Administration (FDA) has approved Bevyxxa (betrixaban) for hospital and extended-dur…

Office-Based Lab Models: Business Operations and Growth Strategies

With Donald S. Cross, MD, FACC; Alberto Gonzalez, MD, FACS; and Kenneth J. Wright, MD, FACS

June 2017—The third in a four-part series discussing office-based labs (OBLs) and ambulatory surgery centers (ASCs) from the perspective of three physicians. This article explores the business operations in an OBL and ASC environment and strategies how to grow the business. Previous articles included OBL development, key issues and lessons learned, and a clinical overview of therapies and devices in the OBL. The final article will focus on trends and predictions for the OBL future.

Twelve-Month NEAT Results Published for TVA Medical's everlinQ endoAVF System

June 15, 2017 -- TVA Medical, Inc. announced that 12-month results from the Novel Endovascular Access Trial (NEAT) were published online by Charmaine E. Lok, MD, et al in Amer…

Ekos Therapy for Postthrombotic Syndrome Evaluated in ACCESS PTS Study

June 16, 2017 -- BTG International announced that results of the ACCESS PTS trial were presented at the Society for Vascular Medicine's 28th annual scientific sessions, he…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.